A long-term cannabis user, looking back across two decades of daily consumption that began at thirteen, offers what science is only now learning to say plainly: that legalization and safety are not the same thing, and that the adolescent brain — still forming its architecture for mood, memory, and impulse — is uniquely vulnerable to lasting harm. The accumulation of research on psychiatric risk and neural change has outpaced the cultural messaging that followed legalization, leaving a generation of young people navigating a substance whose legal status has quietly come to imply a safety it doe
Long-term cannabis user reflects on adolescent risks of early marijuana use
Cobertura Relacionada
Partnered Health's cyber-attack exposed sensitive medical records of patients across 21 Australian clinics, with experts…
BBC News · Jul 16 Actor Sam Neill died from pneumonia, agent confirmsNew Zealand actor Sam Neill, 78, died from pneumonia in Sydney. Best known for Jurassic Park and Peaky Blinders, Neill h…
Google News · Jul 16 Sam Neill, 'Jurassic Park' Star, Dies at 78 From PneumoniaNew Zealand actor Sam Neill, best known for Jurassic Park, died from pneumonia at age 78. His family plans a private mem…
ScienceDaily · Jul 16 CDC Investigates Cyclospora Outbreak Affecting 400+ Across Four Midwest StatesA Cyclospora outbreak has sickened over 400 people across four Midwestern states since May, with investigators still sea…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
This article addresses public health concerns about adolescent cannabis use, not geopolitical matters.
Lente Económico
Personal accounts and research highlight mental health risks from adolescent cannabis use, potentially influencing public health policy and legal cannabis market regulation.
Consumers, particularly parents and adolescents, may face increased healthcare costs for mental health treatment; potential demand for mental health services and psychiatric care may rise; consumers may reduce cannabis purchases due to health concerns.
Likely increased regulatory scrutiny on cannabis marketing to youth, potential age-restriction enforcement, possible requirements for health warnings, increased funding for mental health research and adolescent addiction treatment programs, and potential restrictions on product potency or accessibility.